Basque Health Service

Quick facts

Marketed products

• levo-bupicaine
• Placebo evening
  Placebo evening is an inert substance with no active pharmacological mechanism, used as a control or comparator in clinical studies.

Phase 3 pipeline

• Acetylsalicylic morning · Cardiovascular; Pain management; Inflammation
  Acetylsalicylic acid irreversibly inhibits cyclooxygenase (COX) enzymes, reducing the production of prostaglandins and thromboxane to provide anti-inflammatory, analgesic, and antiplatelet effects.
• ASA evening · Cardiovascular
  Aspirin inhibits platelet aggregation by irreversibly acetylating cyclooxygenase (COX) enzymes, reducing thromboxane A2 production.
• Placebos morning
  Placebos are inert substances that produce therapeutic effects through psychobiological mechanisms including expectation, conditioning, and natural disease course.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Basque Health Service portfolio CI brief
• Basque Health Service pipeline updates RSS